ReviewFrontiers in immunology2026

Advancements in understanding and treating CXCL16/CXCR6 in tumors and in inflammatory diseases: a narrative review.

Xiaohong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.